AUS
NZ
UK
CA
USA
IND
Healthcare
Regeneus Progressing Well To Commercialise Progenza In Japan By 2023; Undertakes strategic capital raising initiatives
August 02, 2019 06:51 PM AEST| By Team Kalkine MediaAustralian clinical-stage regenerative medicine company,?Regeneus Ltd (ASX: RGS) recently announced positive results from its preclinical trial of Progenza in the treatment of allodynia, a condition in which pain occurs from non-painful stimulation o...
Five Pharma Stocks – AVH, MSB, THC, AC8 and CUV
August 02, 2019 04:17 PM AEST| By Team Kalkine MediaThe following pharmaceutical sector companies have recently disclosed their June 2019 quarterly updates. Let us have a brief glance at how these companies faired in the recent three months. AVITA Medical Ltd AVITA Medical Ltd (ASX: AVH), a medicine...
SUDA’s June Quarterly Report Out On ASX; A Look At Its Business And Technology
August 01, 2019 09:40 PM AEST| By Team Kalkine MediaOn 31 July 2019, SUDA Pharmaceuticals Ltd (ASX: SUD), an oro-mucosal drug delivery firm, has released its June quarterly updates on the ASX. SUDA mentioned that it witnessed several key developments during the quarter including restructuring of board...
7 Health Care Stocks With Quarterly Update – ZLD, MX1, SVA, CGS, BNO, TLX And OSL
July 31, 2019 09:48 PM AEST| By Team Kalkine MediaZelda Therapeutics Ltd (ASX: ZLD) Cannabis Group Zelda Therapeutics released its quarterly results for the three months ended 30 June 2019. The company reported a continued progress in its core clinical and preclinical programs and is in the process...
ASX: BOT climbing up the ASX ladder; Progressing Well with its Robust Product Portfolio
July 31, 2019 05:09 PM AEST| By Team Kalkine MediaBotanix Pharmaceuticals Limited (ASX: BOT) is an Australian-headquartered company, engaged in the development of next-gen therapeutics that are safe and effective for the treatment of serious skin diseases. It is a clinical stage cannabinoid company...
Pfizer Signs All-Stock Agreement with Mylan to Create Global Pharma Champion
July 31, 2019 01:17 PM AEST| By Team Kalkine MediaIn the face of a rapidly shifting pharmaceutical market, to be successful, pharmaceutical companies need to innovate, work more efficiently and boost their product portfolios. Moreover, large pharma and biotech companies often engage in merging their...
A Look at Australian Pharma Player, Pharmaxis Ltd’s Products and Its Amine Oxidase Platform
July 29, 2019 07:18 PM AEST| By Team Kalkine MediaAn Australian pharmaceutical research company focussing on fibrotic and inflammatory diseases, Pharmaxis Ltd (ASX: PXS) holds a portfolio of products which are at various stages of development and approval. The product pipeline of the company is cent...
A quick “Check-up” of four Healthcare stocks - 1ST, OSL , IVQ , PIQ
July 29, 2019 01:09 PM AEST| By Team Kalkine MediaAustralia is a powerhouse of biotechnology and pharmaceutical innovation that is being driven by world-class research facilities, leading scientists and a strong yet flexible regulatory regime. Lets us take a look at the following four companies from...
Imugene Releases Bioshares Presentation and Quarterly Updates; Stock Zooms up
July 29, 2019 12:02 PM AEST| By Team Kalkine MediaAn emerging leader in cancer immuno-oncology, Imugene Limited (ASX: IMU) is a clinical stage biotechnology company seeking to develop a range of novel immunotherapies to enhance the efficacy of cancer treatments. Imugene has released its Quarterly A...
Noxopharm secures AU$26 million funding facility to ramp up the development of Veyonda®
July 29, 2019 11:46 AM AEST| By Team Kalkine MediaNoxopharm Limited (ASX: NOX) plans to accelerate the development of Veyonda? on the foundation of its encouraging interim results from both its DARRT-1 and LuPIN studies. The most recent ?interim data supports the company?s belief that its immuno-onc...
Healthcare Stocks In Penny Space - RNO, IDT, SCU
July 28, 2019 08:30 AM AEST| By Team Kalkine MediaAustralia?s pharmaceutical industry is innovative and immensely supports economic prosperity of the nation. The constituent companies not only provide treatments to save lives but also contribute to Australian economy by undertaking business, researc...
A Glimpse At Three Healthcare Stocks: OVN, ANP & BIT
July 26, 2019 08:55 PM AEST| By Team Kalkine MediaIn this piece of writing, we would discuss the three stocks from healthcare sector traded on the ASX. The Australian benchmark index S&P/ASX 200 closed at 6793.4, down by 24.60 points or 0.4% from the previous close, on 26 July 2019. Oventus Med...
2 Important Healthcare Stocks With IT Integration – VHT, PIQ
July 26, 2019 07:19 PM AEST| By Team Kalkine MediaAustralian healthcare industry challenges include an ageing population, increased rate of chronic diseases, emergence and integration of new technologies, etc. Some important Australian companies, which are working on integrating ?SaaS? model in the...
SUDA’s MD and CEO, Mr Stephen Carter Back on Board
July 25, 2019 06:35 PM AEST| By Team Kalkine MediaAn oro-mucosal drug delivery company headquartered in Perth, SUDA Pharmaceuticals Ltd (ASX: SUD) uses its OroMist? technology for the development of low-risk oral sprays. The company reformulates the existing pharmaceuticals into an oral spray to bet...
Journey of Prescient Therapeutics in 2019
July 25, 2019 12:38 PM AEST| By Team Kalkine MediaPrescient Therapeutics Limited (ASX: PTX) is a clinical-stage oncology company that works on mutation causing cancer. The existing product portfolio of the company includes two drug candidates, PTX 100 and PTX 200, under the development phase. Both...
Noxopharm Eyes The Development Of A Well-Tolerated ‘STING agonist’ Drug
July 24, 2019 04:54 PM AEST| By Team Kalkine MediaNoxopharm Limited (ASX: NOX) has released July 2019 edition of its Newsletter called 'Versatility'. The clinical-stage drug development company, Noxopharm reports on the progress of its lead anti-cancer drug candidate Veyonda? achieved over the past...
Three Stocks from the Health Care Sector: ATX, SOM & M7T
July 24, 2019 12:52 PM AEST| By Team Kalkine MediaIn this article, we would discuss three healthcare stocks from ASX. On 23 July 2019, these companies have released significant updates pertaining to their respective business. The Australian benchmark index was trading at 6,780.6, up by 55.4 points (...
Recent Updates On 4 Healthcare Stocks- BNO, MDR, KZA, OPT
July 22, 2019 10:34 PM AEST| By Team Kalkine MediaCompanies and institutions that provide medical assistance and services, manufactures of medical equipment, engage in clinical trials and development of drugs, are part of the healthcare sector. The Australian government makes significant contributio...
An Overview Of IMU’s B-Cell Vaccines’ Clinical Trials
July 22, 2019 07:22 PM AEST| By Team Kalkine MediaAn Australian-based biotechnology company, Imugene Limited (ASX: IMU) focuses on the development of cancer immunotherapies targeted at activating the immune system of cancer patients. The company?s exceptional platform technology helps in stimulating...
SUDA Receives Patent For The Only Effective Medicine For Platelet Reduction, Anagrelide; Stock Soars 33%
July 22, 2019 05:46 PM AEST| By Team Kalkine MediaWith the rise in cases of the deadly disease cancer creating havoc across the globe, it is the need of the hour for the pharma participants to gear up and provide cure and treatment solutions to this global concern. With the huge market opportunity,...
Advertise your brand on Kalkine Media